ROBO Global Healthcare Technology and Innovation ETF
Key Statistics
Historical Performance
Total return including reinvested distributions, from adjusted closing prices.
Price History
Price history is being compiled for this fund.
Top Holdings
Top 25 holdings as of Jan 31, 2026 · source: SEC N-PORT. Full holdings & prospectus →
About HTEC
TheFund normally invests in securities comprising the Index and in depositary receipts representing securities comprising the Index. TheIndex, which is owned and provided by VettaFi LLC (the “Index Provider”), is designed to measure the performance of companiesthat have a portion of their business and revenue derived from the field of healthcare technology as described below and the potentialto grow within this space through innovation and/or market adoption of their products and services (“Healthcare Technology Companies”).Under normal circumstances, the Fund invests at least 80% of its net assets (plus the amount of any borrowings for investment purposes)in securities of Healthcare Technology Companies. Indexcomponents are selected from a proprietary database of Healthcare Technology Companies that are organized into the following sub-sectors:(1) diagnostic; (2) lab process automation; (3) regenerative medicine; (4) precision medicine; (5) data and analytics; (6) telehealth;(7) robotics; (8) medical instruments; and (9) genomics. Each sub-sector’s representation in the Index varies. Eacheligible company is individually analyzed and then given a “HTEC Score” ranging from 1 to 100, comprised of factors representinglevels of revenue a company receives from innovative healthcare technologies, as well as technology and market leadership within thehealthcare technology space. Companies whose HTEC Score is greater than or equal to 50 and that meet the market capitalization and liquidityrequirements described below are eligible for inclusion in the Index. The Index is comprised of a minimum of 50 constituents and a maximumof 100 constituents. Each constituent’s weight in the Index generally is determined by its HTEC Score as a percentage of the totalscore of all constituents. Companies in the Index are reweighted at each rebalance. Scores are reviewed on an ongoing basis by reevaluatingthe factors described above. EligibleIndex components are exchange-listed equity securities of Healthcare Technology Companies that have a market capitalization exceeding$200 million at the time of inclusion in the Index and a minimum trailing 3-month composite average daily volume of $2 million at thetime of inclusion. Existing Index components must maintain a market capitalization of at least $100 million and a minimum trailing 3-monthcomposite average daily volume of $1 million. As of August 1, 2025, the Index comprised 63 securities. As of August 1, 2025, the averagemarket capitalization and average one-year trading volume of the Index components were $35.87 billion and 535.54 million shares, respectively. TheIndex consists of securities of both U.S. and foreign issuers, including securities of issuers located in emerging market countries.The Index Provider expects, under normal circumstances, at least 20% of the Index components to represent securities of non-U.S. issuers.The Index may include China A-shares, which are shares of mainland China-based companies that trade on the Chinese stock exchanges. TheIndex is rebalanced and additions are made quarterly. Deletions from the Index may be made at any time due to changes in business, mergers,acquisitions, bankruptcies, suspensions, de-listings and spin-offs, or for other reasons as determined at the sole discretion of theIndex Provider. Additionally,the Index Provider excludes from Index eligibility any company that does not meet environmental, social and governance (“ESG”)criteria established by the Index Provider. The Index Provider uses a combination of internal research, engagement with companies, anddata from third party ESG research providers when applying its ESG criteria and these criteria generally are applied independently ofbusiness, financial, and other considerations that have been established by the Index Provider for a company’s inclusion in theIndex. TheFund employs a “passive management” investment strategy in seeking to achieve its investment objective. The Fund generallywill use a replication methodology, meaning it will invest in all of the securities comprising the Index in proportion to the weightingsin the Index. However, the Fund may utilize a sampling methodology under various circumstances, including when it may not be possibleor practicable to purchase all of the securities in the Index. The Adviser expects that over time, if the Fund has sufficient assets,the correlation between the Fund’s performance, before fees and expenses, and that of the Index will be 95% or better. A figureof 100% would indicate perfect correlation. TheFund will concentrate its investments (i.e., invest more than 25% of its total assets) in a particular industry or group of industriesto approximately the same extent that the Index concentrates in an industry or group of industries. As of August 1, 2025, the Fund wasconcentrated in the Medical Equipment, Supplies & Distribution Group and the Advanced Medical Equipment & Technology IndustryGroup. In addition, in replicating the Index, the Fund may from time to time invest a significant portion of its assets in the securitiesof companies in one or more sectors. As of August 1, 2025, the Fund had a significant amount of investment exposure in the HealthcareSector. TheFund may invest up to 20% of its assets in investments that are not included in the Index, but which the Adviser believes will help theFund track the Index. TheIndex Provider is not affiliated with the Fund or the Adviser. The Index Provider developed the methodology for determining the securitiesto be included in the Index and for the ongoing maintenance of the Index. The Index is calculated by VettaFi, LLC, which is not affiliatedwith the Fund or the Adviser.
HTEC News
- The Technical Signals Behind (HTEC) That Institutions Follow
- Precision Trading with Robo Global Healthcare Technology And Innovation Etf (HTEC) Risk Zones
- Technical Reactions to HTEC Trends in Macro Strategies
- ROBO Global Healthcare Technology and Innovation ETF (NYSEARCA:HTEC) Trading Down 0.7% – Here’s Why
- HTEC Introduces "OneLoopAi" Redefining How Enterprises Scale AI Into Production
- Technical Reactions to HTEC Trends in Macro Strategies
- HTEC and Embotech Partner to Scale Deployment of Autonomous Driving Solutions for Industrial Logistics
- Trading the Move, Not the Narrative: (HTEC) Edition
- HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit
- HTEC Opens Canada’s First 700 Bar Commercial Heavy-Duty Clean Hydrogen Station
- HTEC Opens Canada’s First 700 Bar Commercial Heavy-Duty Clean Hydrogen Station
- (HTEC) Volatility Zones as Tactical Triggers
Data for HTEC is aggregated from third-party providers (Tiingo, Nasdaq, Finnhub) and SEC filings, may be delayed at least 20 minutes, and may be incomplete or contain errors. Nothing here is investment advice. Verify with the official prospectus before investing.